ISMG Editors: The Battle Over Access to Frontier AI Models

Also: Washington's AI Policy Divide, FDA's Push for AI-Driven Clinical Trials In this week's panel, four ISMG editors discussed the battle over who gets to access powerful AI cybersecurity models, policy issues unfolding in Washington over AI-driven cyber defenses, and how the FDA is beginning to test AI-supported real-time clinical trials to speed up drug development.